← back to search

Xiaojun Liu

Hebei Medical University · CN
Area of research
Oncology · Cancer Research
Research interest
Research interests include CAR-T cell therapy research, Cancer-related molecular mechanisms research, MicroRNA in disease regulation, and RNA modifications and cancer.
h-index
40
citations
11,217
works
480
NIH funding
primary concept
Medicine
email

Recent publications

COPB2 drives gastric cancer progression via PI3K/AKT/NF-κB signaling: a multi-omics and functional study.
2026cited by 0position: contributordoi
Targeting FMO3 suppresses the malignant phenotype of colorectal cancer: evidence from bioinformatics to functional experiments.
2026cited by 0position: contributordoi
Integrative Multi-Omics and Mendelian Randomization Identify Platelet Indices as Causal Mediators in Diabetic Retinopathy
2026cited by 0position: contributordoi
Global, regional and national burden of Metabolic dysfunction-associated steatotic liver disease in adolescents and adults aged 15–49 years from 1990 to 2021: results from the 2021 Global Burden of Disease study
Frontiers in Medicine 2025cited by 5position: middledoi
Dual cytokine-engineered macrophages rejuvenate the tumor microenvironment and enhance anti-PD-1 therapy in renal cell carcinoma
International Immunopharmacology 2025cited by 4position: middledoi
Developing a Panel of Shared Susceptibility Genes as Diagnostic Biomarkers for chronic obstructive pulmonary disease and Heart Failure.
2025cited by 3position: contributordoi
Identification of Ferroptosis‐Related Hub Genes as Diagnosis Biomarkers and Therapeutic Monitoring for Major Depressive Disorder Diagnosis
IET Systems Biology 2025cited by 1position: lastdoi
Identification of HIBCH and MGME1 as Mitochondrial Dynamics-Related Biomarkers in Alzheimer's Disease Via Integrated Bioinformatics Analysis.
2025cited by 1position: contributordoi
Kaempferol inhibited invasion and metastasis of gastric cancer cells by targeting AKT/GSK3β pathway based on network pharmacology and molecular docking.
2025cited by 1position: contributordoi
Identification of Ferroptosis-Related Hub Genes as Diagnosis Biomarkers and Therapeutic Monitoring for Major Depressive Disorder Diagnosis.
2025cited by 1position: contributordoi
Dual oncogenic roles of TPD52 and TPD52L2 in gastric cancer progression via PI3K/AKT activation and immunosuppressive microenvironment remodeling.
2025cited by 1position: contributordoi
BPTF-665aa mediate chromatin remodeling drives chemoresistance in T-LBL/ALL
Journal of Experimental & Clinical Cancer Research 2025cited by 0position: middledoi
PGK1: A Common Biomarker and Therapeutic Target Linking Sarcopenia and Osteoporosis Through Fibroblast-Mediated Pathways.
2025cited by 0position: contributordoi
Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis.
2024cited by 28position: contributordoi
Single‐cell <scp>RNA</scp> sequencing reveals the heterogeneity of <scp>MYH11</scp>+ tumour‐associated fibroblasts between left‐sided and right‐sided colorectal cancer
Journal of Cellular and Molecular Medicine 2024cited by 14position: middledoi
Combined oral low-dose cyclophosphamide endocrine therapy may improve clinical response among patients with metastatic breast cancer via Tregs in TLSs
Scientific Reports 2024cited by 8position: middledoi
Real-time label-free three-dimensional invasion assay for anti-metastatic drug screening using impedance sensing
Frontiers in Pharmacology 2024cited by 4position: middledoi
Anti-inflammatory and DNA Repair Effects of Astragaloside IV on PC12 Cells Damaged by Lipopolysaccharide.
2024cited by 3position: contributordoi
Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2023cited by 34position: middledoi
Mechanisms involved in the HMGB1 modulation of tumor multidrug resistance (Review).
2023cited by 17position: contributordoi
Adherence Behaviors and Related Factors Among Elderly Hypertensive Patients in China: Evidence from the China Health and Retirement Longitudinal Study
Patient Preference and Adherence 2023cited by 14position: lastdoi
Novel mutations of TEX11 are associated with non-obstructive azoospermia
Frontiers in Endocrinology 2023cited by 13position: middledoi
EMT-related gene risk model establishment for prognosis and drug treatment efficiency prediction in hepatocellular carcinoma.
2023cited by 3position: contributordoi
[Inhibitory Effect of Resveratrol on the Proliferation of Multiple Myeloma Cells and the Underlying Mechanism].
PubMed 2023cited by 0position: middledoi
P2X7 Receptor-Induced Bone Cancer Pain by Regulating Microglial Activity via NLRP3/IL-1beta Signaling.
PubMed 2022cited by 20position: middle
lncRNA HOTTIP Recruits EZH2 to Inhibit PTEN Expression and Participates in IM Resistance in Chronic Myeloid Leukemia
Stem Cells International 2022cited by 8position: middledoi
Overexpression of MiR-633 Suppresses the Tumorigenicity of Gastric Cancer Cells and Induces Apoptosis by Targeting MAPK1.
2022cited by 5position: contributordoi
[The Treatment of Newly Diagnosed Primary Immune Thrombocytopenia by Recombinant Human Thrombopoietin Combined with Glucocorticoid].
PubMed 2022cited by 2position: middledoi
Comparative miRNA transcriptomics of macaques and mice reveals <i>MYOC</i> is an inhibitor for <i>Cryptococcus neoformans</i> invasion into the brain
Figshare 2022cited by 0position: firstdoi
Detection and Simulation of Adhesion Coefficient of Residual Snow Pavement on Urban Road
Lecture notes in electrical engineering 2022cited by 0position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 10 papers (2021–2026)Jian‐Min Luo · Hebei Medical University4 papers (2012–2023)Lin Yang · Hebei Medical University4 papers (2018–2022)Zhenzhen Wang · Hebei Medical University3 papers (2022–2023)Lin Yang · Hebei Medical University3 papers (2019–2023)Ying Zhan · Hebei Medical University3 papers (2018–2023)Yuxia Pan · Sichuan University3 papers (2014–2023)Zi-Yuan Nie · Hebei Medical University3 papers (2018–2023)Xiaohui Zhang · Capital Normal University2 papers (2018–2020)Jianmin Luo · Hebei Medical University2 papers (2020–2022)Shu-Peng Wen · Hebei Medical University2 papers (2012–2014)Xiangtao Kang · Guizhou University2 papers (2018–2021)Gongchang Guan · Shanxi Medical University2 papers (2015–2018)Shuping Qiu · 2 papers (2025–2026)Jianmin Luo · Hebei Medical University2 papers (2018–2023) · 2 papers (2018–2021)Meng‐Han Liu · Sichuan University2 papers (2019–2023)Yaqiong Lu · Hebei Medical University2 papers (2019–2023)Junkui Wang · Guangdong University of Technology2 papers (2015–2018)Huixia Zheng · Wenzhou Medical University2 papers (2020–2024)